The clinical value of lymphatic micrometastases in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Verhagen, A
Shirango, H
Thunnissen, E
Tjan-Heijnen, V
van der Drift, M
van der Bruggen, W
Bulten, H
机构：
[1] Radboud Univ, Nijmegen Med Ctr, Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp Nijmegen, Nijmegen, Netherlands
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80882-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S217 / S218
页数：2
相关论文
共 50 条
  • [21] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Pifarre, A
    Monzo, M
    Martin, C
    Sanchez, JJ
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [22] Clinical value of detection of metastasis of carina in patients with non-small cell lung cancer
    Kaynar, Hasan
    Meral, Mehmet
    Ucar, Elif Yilmazel
    Saglam, Leyla
    Yildirim, Umran
    Gorguner, Metin
    Akgun, Metin
    RESPIRATORY MEDICINE, 2011, 105 (10) : 1537 - 1542
  • [23] Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
    Eckardt, J. R.
    Ramlau, R.
    Gervais, R.
    Shepherd, F.
    O'Brien, M.
    Ciuleanu, T.
    Dharan, B.
    Wissel, P.
    Ross, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 387S - 387S
  • [24] Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC)
    Bluthgen, M. V.
    Caramella, C.
    Faivre, L.
    Rosellini, S.
    Facchinetti, F.
    Haspinger, E.
    Ferte, C.
    Ammari, S.
    Michiels, S.
    Soria, J. C.
    Besse, B.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S645 - S646
  • [25] Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patients
    Ma, K. F.
    Chu, X. Y.
    Liu, Y.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01): : 1819 - 1827
  • [26] Clinical value of serum miR-21 as a potential biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Saab, Azza Abdel Rahman
    Raafat, Riham Hazem
    Alkady, Mohammad Sabry
    El Din, Manal M. Kamal
    MEDICAL SCIENCE, 2021, 25 (112) : 1477 - 1485
  • [27] EVALUATION OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER (NSCLC)
    FOEMMEL, RS
    ALEXANDER, NA
    HIRSHAUT, Y
    KATOPODIS, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 182 - 182
  • [28] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Papachristos, A.
    Masinde, S.
    Davis, J. D.
    Gullo, G.
    Rietschel, P.
    Paccaly, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
  • [29] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [30] Intrafractional movement of the oesophagus in patients with Non-Small Cell Lung Cancer (NSCLC)
    Panalkis, N.
    McClelland, J.
    Chandler, A.
    Blackall, J.
    Ahmad, S.
    Hughes, S.
    Hawkes, D.
    Landau, D.
    Brada, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 339 - 340
12345